ROCKVILLE, Md.--(BUSINESS WIRE)--Dec. 2, 2013--
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company
will be webcasting its presentation at the 32nd Annual J.P.
Morgan Healthcare Conference in San Francisco on Tuesday, January 14,
2014 at 9:00 AM Pacific. During the presentation, a member of the
company's management team will provide a corporate overview, which may
include a discussion of the company's recent business developments as
well as preliminary 2013 financial results and financial guidance for
full year 2014. The webcast of this presentation will be available both
live and by replay, accessible from the Emergent website www.emergentbiosolutions.com
under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to
protect and enhance life by offering specialized products to healthcare
providers and governments to address medical needs and emerging health
threats. Additional information about us may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
Source: Emergent BioSolutions Inc.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Vice President, Corporate
Communications
301-795-1800
SchmittT@ebsi.com
